Astrana Health Inc 's Revenue in the fiscal year 2025 $ 3,181.77 millions
Astrana Health Inc 's Revenue in the fiscal year 2024 $ 2,034.54 millions
Astrana Health Inc 's Revenue in the fiscal year 2023 $ 1,386.66 millions
Astrana Health Inc 's Revenue in the fiscal year 2022 $ 1,144.16 millions
Astrana Health Inc 's Revenue in the fiscal year 2021 $ 773.92 millions
ASTH Revenue second quarter 2025 Y/Y Growth Comment
Astrana Health Inc reported Revenue rise of 48.52% year on year in the second quarter 2025, to $ 972.52 millions, this is lower than Astrana Health Inc 's recent average Revenue rise of 84.28%.
Looking into second quarter 2025 results within Consulting Services industry 7 other companies have achieved higher Revenue growth. While Astrana Health Inc ' s Revenue jump of 48.52% ranks overall at the positon no. 1754 in the second quarter 2025.
Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025
Astrana Health Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
542.27 %
24.61 %
-52.25 %
(Dec 31 2017)
ASTH's II. Quarter Q/Q Revenue Comment
Astrana Health Inc achieved in the II. Quarter 2025 below company average Revenue growth of 0.77% quarter on quarter, to $ 972.52 millions.
Within Consulting Services industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Astrana Health Inc 's Revenue growth quarter on quarter, overall rank is 1651.
Astrana Health Inc achieved in the II. Quarter 2025 below company average Revenue growth of 0.77% quarter on quarter, to $ 972.52 millions.
Within Consulting Services industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Astrana Health Inc 's Revenue growth quarter on quarter, overall rank is 1651.
Astrana Health Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 3,844.19
$ 3,526.48
$ 3,181.77
$ 2,896.46
$ 2,419.12
Y / Y Revenue Growth (TTM)
58.91 %
56.69 %
56.39 %
68.17 %
51.97 %
Year on Year Revenue Growth Overall
Ranking
# 321
# 104
# 142
# 355
# 331
Seqeuential Revenue Change (TTM)
9.01 %
10.83 %
9.85 %
19.73 %
7.49 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1754
# 743
# 514
# 1288
# 1001
Cumulative Revenue growth Comment
Although Astrana Health Inc 's Annual Revenue growth year on year were below company's average 84.28% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 58.91% year on year, from 56.69% in Mar 31 2026.
Within the Services sector 23 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 104 to 321.
Although Astrana Health Inc 's Annual Revenue growth year on year were below company's average 84.28% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 58.91% year on year, from 56.69% in Mar 31 2026.
Within the Services sector 23 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 104 to 321.
About Astrana Health Inc Revenue Growth Rates (ASTH), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.